Cargando…

Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review

Recent studies have identified an association between perturbed type I interferon (IFN) responses and the severity of coronavirus disease 2019 (COVID-19). IFNα intervention may normalize the dysregulated innate immunity of COVID-19. However, details regarding its utilization and therapeutic evidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Ling-Ying, Feng, Po-Hao, Yu, Ming-Sun, Chen, Min-Chi, Lin, Alex Jia-Hong, Chen, Justin L., Yu, Lennex Hsueh-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755267/ https://www.ncbi.nlm.nih.gov/pubmed/35115233 http://dx.doi.org/10.1016/j.cytogfr.2022.01.001

Ejemplares similares

Real-world patient characteristics and treatment patterns of polycythemia vera in Taiwan between 2016 and 2017: a nationwide cross-sectional study
por: Tsai, Tsung-Hsien, et al.
Publicado: (2023)

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
por: Zeng, Yan-Ming, et al.
Publicado: (2020)

The effects of Alpha-2a and Beta-1a Interferons on the Coronavirus disease 2019 prognosis
por: Haghbin, Ali, et al.
Publicado: (2023)

A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
por: Chen, Po-Lin, et al.
Publicado: (2020)

Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review
por: Yang, Chih-Jen, et al.
Publicado: (2021)

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
por: Huang, Yin-Qiu, et al.
Publicado: (2020)

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients
por: Yeh, Ming-Lun, et al.
Publicado: (2015)

In vitro diagnostics of coronavirus disease 2019: Technologies and application
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV)
por: Sahu, Kamal Kant, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19): current status and future perspectives
por: Li, Heng, et al.
Publicado: (2020)

Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019
por: Khorramdelazad, Hossein, et al.
Publicado: (2022)

Clinical Utility of Serum Interleukin-8 and Interferon-Alpha in Thyroid Diseases
por: Kobawala, Toral P., et al.
Publicado: (2011)

Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV
por: Lee, Ping-Ing, et al.
Publicado: (2020)

Proposed measures to be taken by ophthalmologists during the coronavirus disease 2019 pandemic: Experience from Chang Gung Memorial Hospital, Linkou, Taiwan
por: Lin, Jui-Yen, et al.
Publicado: (2020)

Management of Hyperacute Stroke during the Coronavirus Disease of 2019 Pandemic: The Modified Code Stroke in a Medical Center in Taiwan
por: Lin, Po-Yu, et al.
Publicado: (2020)

Novel coronavirus 2019 (COVID-19) pandemic outbreak: A comprehensive review of the current literature
por: Ullah, H., et al.
Publicado: (2021)

Novel coronavirus 2019 (COVID-19) pandemic outbreak: A comprehensive review of the current literature
por: Ullah, H., et al.
Publicado: (2021)

Precaution and prevention of coronavirus disease 2019 infection in the eye
por: Chen, Meng-Jou, et al.
Publicado: (2020)

2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China
por: Huang, Wei-Hsuan, et al.
Publicado: (2020)

Coronavirus disease 2019 and acute cerebrovascular events: a comprehensive overview
por: Zhang, Wanzhou, et al.
Publicado: (2023)

Ocular manifestation, comorbidities, and detection of severe acute respiratory syndrome-coronavirus 2 from conjunctiva in coronavirus disease 2019: A systematic review and meta-analysis
por: Ling, Xiao Chun, et al.
Publicado: (2020)

Comprehensive review of coronavirus disease 2019 (COVID-19)
por: Chauhan, Shaylika
Publicado: (2020)

Global coronavirus disease 2019: What has daily cumulative index taught us?
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Current laboratory diagnosis of coronavirus disease 2019
por: Lim, Jihyang, et al.
Publicado: (2020)

Coronavirus disease 2019 in children: Current status
por: Jeng, Mei-Jy
Publicado: (2020)

The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Bupropion for Interferon-Alpha-Induced Depression in Patients with Hepatitis C Viral Infection: An Open-Label Study
por: Chen, Wei-Chun, et al.
Publicado: (2015)

The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak
por: Chen, Andrew Po-Liang, et al.
Publicado: (2021)

Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Comprehensive analysis of expression profile and prognostic significance of interferon regulatory factors in pancreatic cancer
por: Zhang, Ke, et al.
Publicado: (2022)

Current updates and research on plant-based vaccines for coronavirus disease 2019
por: Uthaya Kumar, Asqwin, et al.
Publicado: (2021)

Coronavirus Disease 2019
por: Lin, Sophie, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019
por: O’Brien, Thomas R, et al.
Publicado: (2020)

Interferons Alpha, Beta, and Omega
por: Meager, Anthony
Publicado: (1998)

Somatic pain associated with initiation of interferon-alpha (IFN-α) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study
por: Lin, Chih Ying, et al.
Publicado: (2020)

Equivalent current dipole sources of neurofeedback training-induced alpha activity through temporal/spectral analytic techniques
por: Hsueh, Jen-Jui, et al.
Publicado: (2022)

Temporal Dynamics of Anti–Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019
por: Shaw, Elana R, et al.
Publicado: (2021)

Calcium channel blockers improve prognosis of patients with coronavirus disease 2019 and hypertension
por: Peng, Chi, et al.
Publicado: (2021)

Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019
por: Zhang, Yonghong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ac9nl6ffbmcv7o1jter3nith1k